Is a complete RARE research report available?

No complete published report is available for Ultragenyx Pharmaceutical Inc. (RARE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Ultragenyx Pharmaceutical Inc. (RARE)

NASDAQ: RARE · USD

$17.2

+0.45 (+2.7%)· Recorded snapshot

Market cap	1.7B
Revenue (ttm)	717M
Net income (ttm)	-586M
EPS (ttm)	-$5.83
Shares out	98.3M
Volume	1,952,956
Beta	0.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 717M
Net income (ttm): -586M
EPS (ttm): -$5.83
Market cap: 1.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001515673
Company name	Ultragenyx Pharmaceutical Inc.
Country	United States
Country code	US
CUSIP number	90400D108
Earnings date	2026-11-03
Earnings time	amc
Employees	1,371
Employees change	77
Employees growth	5.95%
Enterprise value	$2.5B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2014-01-31
Is primary listing	Yes
Is SPAC	No
ISIN number	US90400D1081
Last 10-K release date	2026-02-18
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.7B
Market cap category	Small-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$17.20
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	RARE
U.S. state	California
Website	https://www.ultragenyx.com

Metric

Value

Amount currency

USD

CIK code

0001515673

Company name

Ultragenyx Pharmaceutical Inc.

Country

United States

Country code

CUSIP number

90400D108

Earnings date

2026-11-03

Earnings time

amc

Employees

1,371

Employees change

Employees growth

5.95%

Enterprise value

$2.5B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2010

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2014-01-31

Is primary listing

Yes

Is SPAC

ISIN number

US90400D1081

Last 10-K release date

2026-02-18

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.7B

Market cap category

Small-Cap

Next earnings date

2026-11-03

Options

Yes

Price

$17.20

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

RARE

U.S. state

California

Website

https://www.ultragenyx.com

Metric	Value
Earnings yield	-33.88%
EV/Sales	3.42x
FCF / EV yield	-19.93%
FCF yield	-28.98%
Forward EV/Sales	2.82x
Forward P/S	1.94x
P/S ratio	2.35x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-33.88%

EV/Sales

3.42x

FCF / EV yield

-19.93%

FCF yield

-28.98%

Forward EV/Sales

2.82x

Forward P/S

1.94x

P/S ratio

2.35x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-69.46%
EBITDA margin	-64.85%
Gross margin	-20.78%
Operating margin	-69.46%
Pretax margin	-81.17%
Profit margin	-81.73%
Profit per employee	$-427,425
Revenue per employee	$522,976
ROA	-24.22%
ROA (5Y)	-21.76%
ROCE	-54.55%
ROE (5Y)	-233.65%
ROIC	-31.77%
SBC / revenue	19.39%
Tax / revenue	0.56%

Metric

Value

EBIT margin

-69.46%

EBITDA margin

-64.85%

Gross margin

-20.78%

Operating margin

-69.46%

Pretax margin

-81.17%

Profit margin

-81.73%

Profit per employee

$-427,425

Revenue per employee

$522,976

ROA

-24.22%

ROA (5Y)

-21.76%

ROCE

-54.55%

ROE (5Y)

-233.65%

ROIC

-31.77%

SBC / revenue

19.39%

Tax / revenue

0.56%

Metric	Value
EPS growth quarters	1
EPS growth years	3
Net income growth quarters	1
Net income growth years	0
Revenue growth	17.51%
Revenue growth (Q)	28.14%
Revenue growth (QoQ)	57.35%
Revenue growth 10Y	190.07%
Revenue growth 3Y	21.19%
Revenue growth 5Y	14.81%
Revenue growth quarters	1
Revenue growth years	9

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

17.51%

Revenue growth (Q)

28.14%

Revenue growth (QoQ)

57.35%

Revenue growth 10Y

190.07%

Revenue growth 3Y

21.19%

Revenue growth 5Y

14.81%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-4M
Depreciation and amortization	$33M
EBIT	$-498M
EBITDA	$-465M
EPS	$-5.83
FCF per share	$-4.98
Financing cash flow	$397M
Free cash flow	$-489M
Free cash flow minus SBC	$-628M
Gross profit	$-149M
Income taxes	$4M
Investing cash flow	$40M
Net cash flow	$-49M
Net income	$-586M
Operating cash flow minus SBC	$-624M
Operating income	$-498M
Revenue	$717M
Stock-based compensation	$139M

Metric

Value

Capital expenditures

$-4M

Depreciation and amortization

$33M

EBIT

$-498M

EBITDA

$-465M

EPS

$-5.83

FCF per share

$-4.98

Financing cash flow

$397M

Free cash flow

$-489M

Free cash flow minus SBC

$-628M

Gross profit

$-149M

Income taxes

$4M

Investing cash flow

$40M

Net cash flow

$-49M

Net income

$-586M

Operating cash flow minus SBC

$-624M

Operating income

$-498M

Revenue

$717M

Stock-based compensation

$139M

Metric	Value
Altman Z-Score	-4.78
Book value per share	$-2.96
Goodwill	$44M
Interest coverage	-6.47
Long-term assets	$658M
Long-term liabilities	$1.2B
Net cash (debt)	$-766M
Net cash / market cap	-45.39%
Piotroski F-Score	3
Property, plant and equipment	$235M
Shareholders' equity	$-284M
Tangible book value	$-507M
Tangible book value per share	$-5.16
Total assets	$1.3B
Total cash	$292M
Total debt	$1.2B
Total liabilities	$1.5B
WACC	5.71%

Metric

Value

Altman Z-Score

-4.78

Book value per share

$-2.96

Goodwill

$44M

Interest coverage

-6.47

Long-term assets

$658M

Long-term liabilities

$1.2B

Net cash (debt)

$-766M

Net cash / market cap

-45.39%

Piotroski F-Score

Property, plant and equipment

$235M

Shareholders' equity

$-284M

Tangible book value

$-507M

Tangible book value per share

$-5.16

Total assets

$1.3B

Total cash

$292M

Total debt

$1.2B

Total liabilities

$1.5B

WACC

5.71%

Metric	Value
Asset turnover	0.56
Current assets	$606M
Current liabilities	$351M
Current ratio	1.73
Inventory turnover	16.42
Net working capital	$39M
Quick ratio	1.41
Working capital	$255M
Working capital turnover	2.1

Metric

Value

Asset turnover

0.56

Current assets

$606M

Current liabilities

$351M

Current ratio

1.73

Inventory turnover

16.42

Net working capital

$39M

Quick ratio

1.41

Working capital

$255M

Working capital turnover

2.1

Metric	Value
Buyback yield / dilution	-4.22%
Dividend yield	0%
Shareholder yield	-4.22%

Metric

Value

Buyback yield / dilution

-4.22%

Dividend yield

Shareholder yield

-4.22%

Metric	Value
10Y price change	-72.45%
10Y return CAGR	-12.1%
10Y total return	-72.45%
150-day SMA	$23.09
1D price change	2.69%
1M price change	19.24%
1M total return	19.24%
1W price change	7.93%
1W total return	7.93%
1Y price change	-51.03%
1Y return CAGR	-51.06%
1Y total return	-51.03%
20-day SMA	$15.41
200-day SMA	$22.97
3M price change	-35.7%
3M total return	-35.7%
3Y price change	-47.3%
3Y return CAGR	-19.22%
3Y total return	-47.3%
50-day SMA	$17.39
50-day SMA vs 200-day SMA	50under200
52-week high	$39.89
52-week high date	2025-12-08
52-week low	$12.73
52-week low date	2026-09-16
5Y price change	-78.82%
5Y return CAGR	-26.69%
5Y total return	-78.82%
6M price change	-27.93%
6M total return	-27.93%
All-time high	$179.65
All-time high date	2020-12-24
All-time low	$12.73
All-time low date	2026-09-16
Average true range (ATR)	$0.84
Average volume	3.5M
Beta (1Y)	2.34
Beta (2Y)	1.41
Beta (5Y)	0.35
Change from 52-week high	-56.88%
Change from 52-week low	35.11%
Change from all-time high	-90.38%
Change from all-time low	35.82%
Change from open	2.93%
Day's gap	-0.24%
Dollar volume	$33.6M
High price	$17.32
Low price	$16.53
Monthly RSI	37.93
Open price	$16.71
Position in 52-week range	84.81%
Premarket change	-0.66%
Premarket close	$16.75
Premarket price	$16.64
Premarket volume	11.6K
Previous close	$16.75
Price vs 150-day SMA	-25.13%
Price vs 20-day SMA	12.22%
Price vs 200-day SMA	-24.74%
Price vs 50-day SMA	-0.56%
Relative volume	0.56
RSI	60.06
Sharpe ratio	-0.42
Sharpe ratio (3Y)	-0.05
Sharpe ratio (5Y)	-0.26
Sortino ratio	-0.44
Sortino ratio (3Y)	0.02
Sortino ratio (5Y)	-0.24
Volume	2M
Weekly RSI	41.68
YTD price change	-24.83%
YTD total return	-24.83%

Metric

Value

10Y price change

-72.45%

10Y return CAGR

-12.1%

10Y total return

-72.45%

150-day SMA

$23.09

1D price change

2.69%

1M price change

19.24%

1M total return

19.24%

1W price change

7.93%

1W total return

7.93%

1Y price change

-51.03%

1Y return CAGR

-51.06%

1Y total return

-51.03%

20-day SMA

$15.41

200-day SMA

$22.97

3M price change

-35.7%

3M total return

-35.7%

3Y price change

-47.3%

3Y return CAGR

-19.22%

3Y total return

-47.3%

50-day SMA

$17.39

50-day SMA vs 200-day SMA

50under200

52-week high

$39.89

52-week high date

2025-12-08

52-week low

$12.73

52-week low date

2026-09-16

5Y price change

-78.82%

5Y return CAGR

-26.69%

5Y total return

-78.82%

6M price change

-27.93%

6M total return

-27.93%

All-time high

$179.65

All-time high date

2020-12-24

All-time low

$12.73

All-time low date

2026-09-16

Average true range (ATR)

$0.84

Average volume

3.5M

Beta (1Y)

2.34

Beta (2Y)

1.41

Beta (5Y)

0.35

Change from 52-week high

-56.88%

Change from 52-week low

35.11%

Change from all-time high

-90.38%

Change from all-time low

35.82%

Change from open

2.93%

Day's gap

-0.24%

Dollar volume

$33.6M

High price

$17.32

Low price

$16.53

Monthly RSI

37.93

Open price

$16.71

Position in 52-week range

84.81%

Premarket change

-0.66%

Premarket close

$16.75

Premarket price

$16.64

Premarket volume

11.6K

Previous close

$16.75

Price vs 150-day SMA

-25.13%

Price vs 20-day SMA

12.22%

Price vs 200-day SMA

-24.74%

Price vs 50-day SMA

-0.56%

Relative volume

0.56

RSI

60.06

Sharpe ratio

-0.42

Sharpe ratio (3Y)

-0.05

Sharpe ratio (5Y)

-0.26

Sortino ratio

-0.44

Sortino ratio (3Y)

0.02

Sortino ratio (5Y)

-0.24

Volume

Weekly RSI

41.68

YTD price change

-24.83%

YTD total return

-24.83%

Metric	Value
Float	74.1M
Float percentage	75.39%
Shares change (QoQ)	1.29%
Shares change (YoY)	4.22%
Shares held by insiders	3.61%
Shares held by institutions	96.93%
Shares outstanding	98.3M
Short % of float	27.46%
Short % of shares	20.7%
Short ratio	3 days

Metric

Value

Float

74.1M

Float percentage

75.39%

Shares change (QoQ)

1.29%

Shares change (YoY)

4.22%

Shares held by insiders

3.61%

Shares held by institutions

96.93%

Shares outstanding

98.3M

Short % of float

27.46%

Short % of shares

20.7%

Short ratio

3 days

Ultragenyx Pharmaceutical Inc. (RARE)

Price

Financial snapshot

Fair-value bridge

Latest news · RARE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RARE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on RARE

Frequently asked questions